Understanding Positive and Negative Controls in Microbiology Experiments

Positive and negative controls are essential reference standards in microbiology experiments that validate test performance by providing known outcomes for comparison. A positive control is a sample known to produce a detectable result (e.g., growth of a target organism, a specific staining reaction), confirming that the experimental system can detect the target. A negative control is a sample known to produce no detectable result (e.g., sterile medium, a known non-reactive organism), confirming that observed results are not due to contamination, reagent artifacts, or procedural errors. These controls are indispensable whenever you need to distinguish true positive findings from false signals, whether in culture-based isolation, biochemical identification, staining procedures, or diagnostic assays. Without controls, you cannot determine if a negative result means the target is absent or the test failed, nor if a positive result reflects genuine detection or contamination.

At a Glance

Scientific Principle of Controls in Microbiology

The fundamental logic of experimental controls rests on the concept of known reference points. In microbiology, you work with living organisms and complex reagents, both of which can behave unpredictably. Controls provide a baseline against which you interpret your experimental results.

A positive control demonstrates that your experimental conditions support detection of the target. For example, if you are testing a new batch of selective agar for isolating Salmonella, inoculating a known Salmonella strain onto the plate should produce characteristic colonies. If it does not, the medium may be defective, incubation conditions may be wrong, or the organism may have lost viability. Without this control, a negative result from a clinical sample could be misinterpreted as absence of Salmonella when the test itself failed.

A negative control demonstrates that your reagents, equipment, and technique do not introduce false positives. In the same selective agar example, a sterile swab streaked onto the plate should show no growth. If colonies appear, your medium, saline, or technique is contaminated, and any positive results from test samples are suspect.

The importance of controls extends beyond simple presence-absence tests. In quantitative assays, controls establish the dynamic range and limit of detection. In staining procedures, controls confirm that the staining reagents are working correctly and that the decolorization step is properly timed. In diagnostic metagenomics, negative controls are critical for distinguishing true pathogen sequences from environmental or reagent contaminants, especially in low-biomass samples where contamination can dominate sequencing reads [2].

Materials and Instrumentation Choices

The specific materials for controls depend on your experimental system, but general principles apply across microbiology.

Positive Control Materials

For culture-based work, positive controls require verified reference strains. These should be:

• Authenticated: Obtain from reputable culture collections (e.g., ATCC, NCTC, DSMZ) or your laboratory's quality control program
• Viable: Use fresh cultures or properly stored stocks with documented viability
• Appropriate: Match the target organism you intend to detect. For Gram staining, use both Staphylococcus aureus (Gram-positive) and Escherichia coli (Gram-negative) as separate positive controls
• Quantified: For assays requiring specific inocula, prepare standardized suspensions (e.g., 0.5 McFarland standard)

For biochemical tests, positive controls include known reactive organisms. For a urease test, Proteus mirabilis serves as a positive control because it rapidly hydrolyzes urea. For a coagulase test, Staphylococcus aureus provides the positive reaction.

For diagnostic assays, positive controls may be:

• Cultured pathogen suspensions at known concentrations
• Commercially available positive control materials
• Spiked clinical matrices (e.g., pathogen added to pooled negative urine)

Negative Control Materials

Negative controls should contain everything present in test samples except the target. Common choices include:

• Sterile medium: The same broth or agar used for test samples, processed identically
• Sterile diluent: Saline, PBS, or buffer used for sample preparation
• Known negative matrix: Pooled clinical specimens confirmed negative by reference methods
• Reagent controls: For staining, a slide processed with all reagents except the primary stain

Instrumentation Considerations

When using automated platforms, controls must be compatible with the system. For example, commercial PCR assays for monkeypox virus detection on platforms like BD MAX, Alinity m, or Argene require specific control materials validated for each platform [3]. Always consult the manufacturer's instructions for recommended positive and negative control materials.

For metagenomic sequencing, negative controls are particularly important because sequencing can detect trace amounts of DNA from reagents, laboratory surfaces, or personnel. A framework integrating negative controls with lab-specific contaminant watchlists and computational filtering substantially improves contamination management and reduces false-positive signals [2].

Designing Controls for Common Microbiology Procedures

Culture-Based Isolation

When culturing clinical or environmental samples, include:

• Positive control: A plate inoculated with the target organism at a concentration expected to yield isolated colonies
• Negative control: An unopened plate from the same batch incubated alongside test plates, or a plate streaked with sterile inoculating fluid

For selective media, the positive control should include both target organisms (should grow) and non-target organisms (should be inhibited) to verify selectivity.

Gram Staining

Gram staining requires two positive controls and one negative control:

• Positive control 1: Known Gram-positive organism (e.g., Staphylococcus aureus)
• Positive control 2: Known Gram-negative organism (e.g., Escherichia coli)
• Negative control: A slide processed through all staining steps but with sterile water or buffer substituted for the primary stain (crystal violet)

The Gram-positive and Gram-negative controls confirm that the staining reagents and decolorization step are working correctly. The negative control confirms that no color develops from reagents alone. Note that some bacteria, such as certain Bacillaceae strains, may stain Gram-negative despite having a monoderm (single membrane) architecture with thick peptidoglycan, challenging the traditional Gram classification [5]. This underscores why known reference strains are essential controls.

Biochemical Identification Tests

For each biochemical test (e.g., urease, coagulase, oxidase, catalase):

• Positive control: Inoculate a tube or test area with a known reactive organism
• Negative control: Inoculate a tube or test area with a known non-reactive organism, or process a tube with sterile inoculum

For example, in a urease test, include Proteus mirabilis (positive, turns pink-red) and Escherichia coli (negative, no color change). The negative control confirms that the medium itself does not produce a color change.

Diagnostic Assays (ELISA, PCR, Sequencing)

Diagnostic assays require more extensive controls:

• Positive control: A sample containing the target at a known concentration near the assay's limit of detection
• Negative control: A sample confirmed free of the target, processed identically to test samples
• Extraction control: A sample processed through nucleic acid extraction to verify recovery
• Inhibition control: For PCR, a sample spiked with a known amount of target to detect inhibitors

In a sandwich ELISA for talaromycosis, the assay demonstrated 88.61% sensitivity and 96.06% specificity when evaluated against culture-confirmed cases and non-talaromycosis controls [4]. These performance metrics depend on proper controls during validation and routine use.

For metagenomic sequencing, negative controls are essential for distinguishing true pathogen sequences from contaminants. A study applying mNGS to 144 clinical samples established a framework integrating negative controls, lab-specific contaminant watchlists, and computational filtering to reduce false-positive signals [2]. Without these controls, spurious detections can lead to incorrect clinical conclusions.

Conceptual Workflow for Implementing Controls

Step 1: Define the Experimental Question

Before selecting controls, clearly state what you are testing. Are you determining presence or absence of a specific organism? Quantifying bacterial load? Identifying an unknown isolate? The experimental question determines which controls are necessary.

Step 2: Select Appropriate Control Materials

Choose positive and negative controls that match your test system. For culture, use reference strains with known characteristics. For staining, use organisms with predictable staining properties. For diagnostic assays, use validated control materials.

Step 3: Prepare Controls Simultaneously with Test Samples

Process controls through every step that test samples undergo. This includes:

• Same reagents and media
• Same incubation conditions (temperature, atmosphere, time)
• Same equipment and instruments
• Same technician or protocol

The key principle is that controls must experience identical conditions to test samples, except for the presence or absence of the target.

Step 4: Include Controls at Appropriate Frequency

For routine testing, include at least one positive and one negative control per batch or run. For large batches (e.g., >20 samples), consider multiple controls distributed throughout the run to detect positional effects. For new reagent lots or equipment, increase control frequency.

Step 5: Document Control Results

Record control results in your laboratory notebook or electronic system. Include:

• Control identity and source
• Expected result
• Observed result
• Any deviations from expected
• Corrective actions taken if controls fail

Step 6: Interpret Test Results Based on Controls

Only interpret test sample results if controls perform as expected. If either control fails, results are unreliable and the experiment must be repeated after troubleshooting.

Quality Checks and Control Acceptance Criteria

Establish clear criteria for accepting or rejecting control results before beginning experiments.

Positive Control Acceptance Criteria

• Culture: Expected growth characteristics (colony morphology, color, size) within specified time
• Staining: Expected color and morphology (e.g., purple cocci for Gram-positive, pink rods for Gram-negative)
• Biochemical tests: Expected reaction (color change, gas production, clot formation) within specified time
• Diagnostic assays: Signal (OD, Ct value, fluorescence) within established range

Negative Control Acceptance Criteria

• Culture: No growth after full incubation period
• Staining: No color development (or only expected counterstain color if applicable)
• Biochemical tests: No reaction (no color change, no gas, no clot)
• Diagnostic assays: No signal above threshold, or signal within established negative range

When Controls Fail

If positive control fails (no expected result):

• Check reagent viability and expiration
• Verify incubation conditions (temperature, atmosphere, time)
• Confirm organism viability using a non-selective medium
• Repeat with fresh control materials

If negative control fails (unexpected positive result):

• Identify contamination source (reagents, equipment, technique)
• Replace all reagents with fresh stocks
• Decontaminate work area and equipment
• Repeat with strict aseptic technique

In a clinical validation of a urine NGS assay, internal controls ensured standardized, high-stringency results, achieving 97.2% sensitivity and 99.6% specificity [1]. This level of performance depends on rigorous control implementation.

Result Interpretation with Controls

Scenario 1: Both Controls Pass

Test results are interpretable. A positive test sample indicates detection of the target. A negative test sample indicates absence of the target (within the assay's detection limits).

Scenario 2: Positive Control Fails, Negative Control Passes

Test results are unreliable. The negative results may be false negatives because the system failed to detect the target. Do not report negative results. Investigate why the positive control failed before repeating.

Scenario 3: Positive Control Passes, Negative Control Fails

Test results are unreliable. Positive results may be false positives due to contamination. Do not report positive results. Identify and eliminate the contamination source before repeating.

Scenario 4: Both Controls Fail

Systematic failure. All results are unreliable. Investigate both control failures. Common causes include expired reagents, instrument malfunction, or widespread contamination.

Edge Cases

Weak positive control: If the positive control produces a weak but detectable signal, the assay may be operating near its limit of detection. Consider whether test samples with low target levels could be missed. Repeat with a stronger positive control if needed.

Contamination in negative control: Even a single colony in a negative control invalidates all positive results in that batch. However, if the contaminant is morphologically distinct from the target, you may still interpret negative results with caution, but document the finding.

Multiple negative controls: If you include several negative controls and only one shows contamination, the contamination may be localized (e.g., from a specific pipette tip). Investigate and repeat affected samples.

Troubleshooting Common Control Problems

Limitations of Controls

Controls are powerful but have limitations that every microbiologist should understand.

Controls Do Not Guarantee Perfect Performance

Even with proper controls, false results can occur. Controls confirm that the system works under the tested conditions, but they cannot detect every possible failure mode. For example, a positive control may grow well while a test sample fails to grow due to inhibitors present only in the test sample.

Controls May Not Represent All Test Conditions

A single positive control strain may not represent all strains of that species. Some strains may have different growth requirements, staining properties, or biochemical reactions. Use multiple positive controls when testing diverse targets.

Negative Controls Cannot Detect All Contamination

A negative control detects contamination introduced during processing, but it cannot detect contamination that occurs after the control is processed. For example, if a test sample becomes contaminated during storage after the negative control has been processed, the negative control will not reveal this.

Controls Add Cost and Time

Including controls increases reagent consumption, processing time, and data analysis requirements. However, the cost of unreliable results far exceeds the cost of controls. Laboratories must balance control frequency with practical constraints.

Controls in Complex Assays

In metagenomic sequencing, even with rigorous negative controls, some contaminant sequences may persist. A framework integrating negative controls with computational filtering and lab-specific contaminant watchlists substantially improves contamination management but cannot eliminate it entirely [2]. Similarly, in diagnostic assays, controls provide confidence but cannot guarantee 100% accuracy.

Documentation Requirements

Proper documentation of controls is essential for quality assurance, troubleshooting, and regulatory compliance.

What to Document

For each experiment, record:

• Date and time of experiment
• Technician name
• Control identity and source (e.g., ATCC number, lot number)
• Expected result for each control
• Observed result for each control
• Any deviations from standard protocol
• Corrective actions taken if controls fail
• Final interpretation of test results based on controls

Documentation Formats

• Laboratory notebook: For research and teaching laboratories
• Electronic laboratory information system: For clinical and diagnostic laboratories
• Batch records: For manufacturing and quality control
• Control charts: For monitoring control performance over time

Retention Requirements

Follow your institution's policies for record retention. Clinical laboratories typically retain records for years as required by regulatory standards. Research laboratories should retain records at least until results are published or the project concludes.

Biosafety Considerations

Controls must be handled with the same biosafety precautions as test samples. Even though control organisms are typically well-characterized and non-pathogenic, standard microbiological practices apply.

BSL-1 Practices for Routine Controls

For teaching laboratories and routine quality control using BSL-1 organisms (e.g., Escherichia coli K-12, Staphylococcus aureus non-toxigenic strains, Saccharomyces cerevisiae):

• Perform work on open bench with standard aseptic technique
• Decontaminate work surfaces before and after use
• Use personal protective equipment (lab coat, gloves, safety glasses)
• Dispose of all cultures and contaminated materials in biohazard waste
• Wash hands after handling cultures

BSL-2 Considerations

If controls include organisms classified at BSL-2 (e.g., Salmonella enterica, Staphylococcus aureus with toxin production, Neisseria gonorrhoeae):

• Perform work in a biological safety cabinet
• Limit access to laboratory during procedures
• Use additional PPE as required by institutional biosafety committee
• Follow institutional protocols for waste decontamination

General Biosafety Principles

The CDC and NIH provide authoritative guidance for biosafety in microbiological and biomedical laboratories [6]. Key principles include:

• Conduct risk assessments for all organisms used as controls
• Use appropriate containment based on risk assessment
• Decontaminate all cultures before disposal
• Never use pathogenic organisms as controls in teaching laboratories without appropriate containment

For research involving recombinant or synthetic nucleic acid molecules, follow the NIH Guidelines [7], which provide institutional and biosafety frameworks for such work.

Frequently Asked Questions

Can I use the same organism for both positive and negative controls?

No. A positive control must contain the target and produce a detectable result. A negative control must lack the target and produce no detectable result. Using the same organism for both would defeat the purpose of controls. For example, in a urease test, you cannot use Proteus mirabilis as both positive and negative control because it always produces a positive reaction.

How many controls should I include per experiment?

Include at least one positive and one negative control per batch or run. For larger batches (more than 20 samples), consider multiple controls distributed throughout the run. For critical experiments or when using new reagents, increase control frequency. Clinical diagnostic assays typically require controls at the beginning and end of each run, plus additional controls for each new reagent lot.

What should I do if my negative control shows contamination but my test samples are negative?

If the negative control shows contamination but all test samples are negative, the contamination may have occurred after the test samples were processed, or the contaminant may be present at levels below detection in test samples. Do not report results as valid. Investigate the contamination source, decontaminate, and repeat the entire experiment. Even if test samples appear negative, you cannot be confident they were not contaminated.

Can I skip controls if I am using commercial kits that claim to include internal controls?

No. Commercial kits may include internal controls (e.g., internal amplification controls for PCR), but these do not replace external positive and negative controls. Internal controls verify that individual reactions worked, but they do not detect batch-level contamination, reagent lot failures, or systematic errors. Always include external positive and negative controls processed alongside test samples.

References and Further Reading

1. Couto-Rodriguez M, Danko DC, Wells HL, et al. Analytical validation of a highly accurate and reliable next-generation sequencing-based urine assay. 2026. https://pubmed.ncbi.nlm.nih.gov/42012213/ — Describes use of internal controls in clinical NGS validation for urine pathogen detection.

2. Ibañez-Lligoña M, Colomer-Castell S, Campos C, et al. Unveiling pathogens and contaminants: refining metagenomics for clinical diagnostics. 2026. https://pubmed.ncbi.nlm.nih.gov/42005844/ — Establishes framework for negative controls and contaminant filtering in clinical metagenomics.

3. Usal M, Andréani J, Truffot A, et al. Evaluation and comparison of three qPCR commercial assays and three automated platforms for the detection of monkeypox virus DNA. 2026. https://pubmed.ncbi.nlm.nih.gov/42132395/ — Compares commercial PCR assays with control materials across multiple platforms.

4. Wei H, Amsri A, Thammasit P, et al. Diagnostic performance of a biotin-labeled 4D1 sandwich ELISA for serum antigen detection in talaromycosis. 2026. https://pubmed.ncbi.nlm.nih.gov/42085450/ — Reports sensitivity and specificity of ELISA with control groups.

5. García-Miranda N, Cantellano ME, Hernández-Tamayo R, et al. Gram-negative-staining Bacillaceae with thick cell wall and monoderm architecture uncover evolutionary diversity and challenge Gram-based classification. 2026. https://pubmed.ncbi.nlm.nih.gov/42034801/ — Demonstrates limitations of Gram staining and importance of reference controls.

6. CDC and NIH. Biosafety in Microbiological and Biomedical Laboratories (BMBL), 6th Edition. 2020. https://www.cdc.gov/labs/bmbl/index.html — Authoritative biosafety guidance for microbiological laboratories.

7. National Institutes of Health. NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules. https://osp.od.nih.gov/policies/biosafety-and-biosecurity-policy/nih-guidelines-for-research-involving-recombinant-or-synthetic-nucleic-acid-molecules/ — Framework for biosafety in recombinant nucleic acid research.

8. National Center for Biotechnology Information. NCBI Bookshelf: Molecular Biology and Laboratory Methods. https://www.ncbi.nlm.nih.gov/books/ — Searchable collection of biomedical methods references.

Related Articles

• How to Perform a Coagulase Test: Slide and Tube Methods
• Aseptic Technique in Microbiology: Essential Steps and Common Mistakes
• Pour Plate Method: Principle, Procedure, and Applications in Microbiology
• How to Perform a Urease Test: Principle, Procedure, and Interpretation
• Aseptic Technique in Microbiology Lab: Essential Steps and Best Practices
• How to Prepare Agar Plates for Microbiology: Pouring and Storage Guidelines